Literature DB >> 11790541

IL-1 and IL-18 receptors, and their extended family.

John E Sims1.   

Abstract

The cytokines IL-1 and IL-18 are key molecules in both the innate and the adaptive immune response. Recently, important insights have been gained into the regulation of their functions. Moreover, it has become apparent that they are members of a larger family of related receptors, some of which can also be shown to contribute to host defense.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11790541     DOI： 10.1016/s0952-7915(01)00306-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  45 in total

Review 1.  The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders.

Authors:  H E Barksby; S R Lea; P M Preshaw; J J Taylor
Journal:  Clin Exp Immunol       Date:  2007-06-21       Impact factor: 4.330

2.  Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells.

Authors:  Ana Reynders; Nadia Yessaad; Thien-Phong Vu Manh; Marc Dalod; Aurore Fenis; Camille Aubry; Georgios Nikitas; Bertrand Escalière; Jean Christophe Renauld; Olivier Dussurget; Pascale Cossart; Marc Lecuit; Eric Vivier; Elena Tomasello
Journal:  EMBO J       Date:  2011-06-17       Impact factor: 11.598

3.  Resistin deficiency in mice has no effect on pulmonary responses induced by acute ozone exposure.

Authors:  Shehla S Razvi; Jeremy B Richards; Farhan Malik; Kevin R Cromar; Roger E Price; Cynthia S Bell; Tingting Weng; Constance L Atkins; Chantal Y Spencer; Katherine J Cockerill; Amy L Alexander; Michael R Blackburn; Joseph L Alcorn; Ikram U Haque; Richard A Johnston
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

4.  Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice.

Authors:  Richard A Johnston; Joseph P Mizgerd; Lesley Flynt; Lee J Quinton; Erin S Williams; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

5.  Inhibition of transforming growth factor-beta signalling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice.

Authors:  S Segawa; D Goto; Y Yoshiga; M Sugihara; T Hayashi; Y Chino; I Matsumoto; S Ito; T Sumida
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

Review 6.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

Review 7.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

8.  Interleukin-18 facilitates the early antimicrobial host response to Escherichia coli peritonitis.

Authors:  Sebastiaan Weijer; Miguel E Sewnath; Alex F de Vos; Sandrine Florquin; Koen van der Sluis; Dirk J Gouma; Kiyoshi Takeda; Shizuo Akira; Tom van der Poll
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  TILRR, a novel IL-1RI co-receptor, potentiates MyD88 recruitment to control Ras-dependent amplification of NF-kappaB.

Authors:  Xiao Zhang; Freya Shephard; Hong B Kim; Ian R Palmer; Selina McHarg; Gregory J S Fowler; Luke A J O'Neill; Endre Kiss-Toth; Eva E Qwarnstrom
Journal:  J Biol Chem       Date:  2009-11-25       Impact factor: 5.157

Review 10.  Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy.

Authors:  N M Luheshi; N J Rothwell; D Brough
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.